| 000 | 01271 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514055222.0 | ||
| 264 | 0 | _c20030605 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a1084-9785 | ||
| 024 | 7 |
_a10.1089/108497802320970307 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLamonica, D | |
| 245 | 0 | 0 |
_aRadioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL). _h[electronic resource] |
| 260 |
_bCancer biotherapy & radiopharmaceuticals _cDec 2002 |
||
| 300 |
_a689-97 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdiagnostic imaging |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aRadioimmunodetection |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 700 | 1 | _aCzuczman, M | |
| 700 | 1 | _aNabi, H | |
| 700 | 1 | _aKlippenstein, D | |
| 700 | 1 | _aGrossman, Z | |
| 773 | 0 |
_tCancer biotherapy & radiopharmaceuticals _gvol. 17 _gno. 6 _gp. 689-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/108497802320970307 _zAvailable from publisher's website |
| 999 |
_c12339560 _d12339560 |
||